Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

• Prif Awduron: Herbertz S (Awdur), Sawyer JS (Awdur), Stauber AJ (Awdur), Gueorguieva I (Awdur), Driscoll KE (Awdur), Estrem ST (Awdur), Cleverly AL (Awdur), Desaiah D (Awdur), Guba SC (Awdur), Benhadji KA (Awdur), Slapak CA (Awdur), Lahn MM (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Dove Medical Press, 2015-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Stephan Herbertz,1 J Scott Sawyer,2 Anja J Stauber,2 Ivelina Gueorguieva,3 Kyla E Driscoll,4 Shawn T Estrem,2 Ann L Cleverly,3 Durisala Desaiah,2 Susan C Guba,2 Karim A Benhadji,2 Christopher A Slapak,2 Michael M Lahn21Lilly Deutschland GmbH, Bad Homburg, Germany; 2Lilly Research Laboratori...